Get started
Author

Jerryes Pious Wisely

Observed names: J.P. Wisely, Jerryes Wisely
ORCID: 0000-0003-0766-6713
Observed ORCID: 0000-0003-0766-6713
OpenAlex ID: A5031092722
Nivolumab usage patterns combined with TKI for mRCC: Financial toxicity and clinical outcomes from self-paying patients in India—Is low dose an option when access is limited?
2023 · Ajoy Oommen John, Josh Thomas Thomas Georgy, et al. · Journal of Clinical Oncology · 3
210MO Low dose nivolumab with TKI in mRCC: Dosing strategies, de-escalation and survival among self-paying patients in India
2023 · A.O. John, J.T. Georgy, et al. · Annals of Oncology · 1
PDF
370P Low-dose nivolumab with induction chemotherapy for inoperable HNSCC in 111 patients: Response rates, survival, and implications for LMICs
2023 · J.T. Georgy, Z. Thomas, et al. · Annals of Oncology · 1
PDF
Beyond the Expected: Life-Threatening Immune-Related Adverse Events from Checkpoint Blockade — A Case Series
2026 · Punam Rabha, Ashutosh Jain, et al. · Zenodo (CERN European Organization for Nuclear Research)
ABCL-536: Complete Metabolic Responses to Checkpoint Inhibitor Therapy in Patients With PD-L1–Enriched Relapsed/Refractory DLBCL Ineligible for Intensive Therapy: A Real-World Case Series From an LMIC Tertiary Center
2026 · Jerryes Pious Wisely, Ashutosh Jain, et al. · Clinical Lymphoma Myeloma & Leukemia
Outcomes of synovial sarcoma and the role of the Sarculator nomogram in guiding adjuvant chemotherapy: A single-institution retrospective real-world study
2026 · Ashutosh Jain, Punam Rabha, et al. · International journal of oncology research.
PDF
10eP Prognostic factors and outcomes of primary CNS lymphoma treated with high-dose methotrexate-based chemotherapy: A 12-year experience from North India
2026 · P. Rabha, V. Raina, et al. · ESMO rare cancers.
PDF
174P Outcomes of synovial sarcoma patients and use of sarculator in guiding adjuvant treatment: A retrospective real-world data
2026 · P. Rabha, A. Jain, et al. · ESMO rare cancers.
PD-1 Inhibition and the Changing Frontline Landscape of Advanced Classical Hodgkin Lymphoma: A Narrative Review with a Focus on Applicability in Lower- and Middle-Income Settings
2026 · Ashutosh Jain, Punam Rabha, et al. · International Journal of All Research Education & Scientific Methods
Primary pleural small cell carcinoma with massive pleural effusion: A rare case report
2025 · Punam Rabha, Jerryes Pious Wisely, et al. · International Journal of Surgery Case Reports
Abstract PO5-03-11: Ultra-low dose nivolumab added to dose-dense, cisplatin-based neoadjuvant chemotherapy in locally advanced, borderline operable triple negative breast cancer: A matched case-control study
2024 · Zachariah Thomas, Josh Georgy, et al. · Cancer Research
618P Adult renal Ewing’s sarcoma/primitive neuroectodermal tumor: A 20-year retrospective review of molecular histopathological profiles, and clinical outcomes
2023 · J.T. Georgy, Z. Thomas, et al. · Annals of Oncology
PDF
504P Real-world outcomes with induction systemic therapy for stage III in eligible for upfront local therapy: Pre vs post immunotherapy era in a tertiary referral centre
2023 · P.K. Marimuthu, A. Singh, et al. · Annals of Oncology
PDF
78P Dose-dense epirubicin and cisplatin (ddEP) in localised osteosarcoma
2023 · Z. Thomas, J.T. Georgy, et al. · ESMO Open
PDF
196P Molecular profiling to identify recurrent mutations comparing pre and post-neoadjuvant chemotherapy tumour specimens of TNBC patients with residual disease
2022 · J.T. Georgy, A. Singh, et al. · Annals of Oncology
PDF
Incidence and Outcomes of Para-aortic Nodal Recurrence After Definitive Treatment for Cervical Cancer: A Single Institution Experience from South India
2020 · Jerryes Pious Wisely, Anitha Thomas, et al. · Indian Journal of Gynecologic Oncology
Barrier Skin Film vs. Steroid cream prophylaxis for prevention of radiation dermatitis in breast cancer women undergoing adjuvant radiation therapy
2020 · Jerryes Pious Wisely
Works count: 17
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type